With a shortage of new tuberculosis drugs in the pipeline, a software tool can predict how current drugs--including unlikely candidates -- can be combined in new ways to create more effective treatments.
from Top Health News -- ScienceDaily https://ift.tt/347YrWA
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
The IT major further said the Ebit margin for the current quarter is expected to be between 20.5-21 per cent from Home Page https://ift.tt...
-
New heat-harnessing 'solar' cells that reflect 99% of the energy they can't convert to electricity could help bring down the pri...
-
Researchers have combined embryonic cells and liver cells in a new cell culture test. This combination lets them detect adverse effects that...
No comments:
Post a Comment